The value of CT arterial enhancement fraction combined with serum NLR and CRP in the prognosis of patients with decompensated cirrhosis
Objective:To evaluate the value of CT arterial enhancement fraction combined with serum NLR and CRP in the prognosis of patients with decompensated cirrhosis.Methods:A total of 120 patients with decompensated cirrhosis admitted to Dafeng Hospital,Chaoyang District,Shantou City from April 2019 to April 2022 were selected as the study objects.The patients were followed up for 1 year.Taking death as the end event,the patients were divided into survival group(n=84)and death group(n=36).Multivariate Logistic regression was used to analyze the relationship between CT arterial enhancement score,serum NLR and CRP and prognosis of patients with decompensated cirrhosis,and ROC curve was drawn to analyze the predictive value of CT arterial enhancement fractioncombined with serum NLR and CRP for prognosis of patients with decompensated cirrhosis.Results:Multivariate Logistic regression analysis showed that increased HAEF(OR=1.941),increased H/S(OR=1.815),decreased PTA(OR=2.100),decreased ALB(OR=2.008),increased NLR(OR=2.079)and increased CRP(OR=2.134)were independent risk factors for prognosis of decompensated cirrhosis patients(P<0.05).ROC curve analysis results showed that the levels of HAEF,H/S,NLR,CRP and AUC of combined detection were 0.862,0.808,0.831,0.933,0.989,respectively,and combined detection was superior to single detection(P<0.05).Conclusion:CT arterial enhancement fraction combined with serum NLR and CRP has a good value in evaluating the prognosis of patients with decompensated cirrhosis.
cirrhosisdecompensation periodCT arterial enhancement fractionneutrophil/lymphocyte ratioC-reactive protein
NETL
NSTL
万方数据
